Which of the following are clinical findings of Tay-Sachs disease in the newborn? (Select all that apply.)

An infant was born 2 hours ago at 37 weeks of gestation and weighing 4.1 kg (9lbs.). The infant appears chubby with a flushed complexion and is very tremulous. The tremors are most likely the result of

A new father wants to know what medication was put into his infant’s eyes and why it is needed. The nurse explains to the father that the purpose of the erythromycin ophthalmic ointment is to

Name and define the four (4) methods of heat loss in a newborn.

While evaluating the reflexes of a newborn, the nurse notes the infant extends an arm and leg on one side of the body to which the infant’s head simultaneously turns. The nurse would document this finding as a positive

Name and give the onset times of the three (3) types of hyperbilirubinemia in the newborn.

Drug A exhibits an oral bioavailability (F) of 42%. After a 10‑mg oral dose, 2.8 mg of unchanged drug is recovered in the feces. Biliary excretion is assumed negligible and the liver is the only site of metabolism. What should be its extraction ratio (ER) value? 

Which of the following leads to a modification in the metabolic activity of an enzyme toward a drug?

In a bioavailability study, a healthy volunteer received 100 mg of Drug A intravenously, resulting in AUC0–24h and AUC0–∞ values of 1.34 and 1.76 mg·h/L, respectively. After the same subject received a 250‑mg oral dose of Drug A, the corresponding AUC0–24h and AUC0–∞ values were 1.71 and 2.34 mg·h/L. The oral bioavailability (F) of Drug A in this subject is calculated to be:

Regarding the determinants of the rate and extent of drug distribution, which of the following statements is correct?